Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

RSV is a common virus that affects the lungs and breathing passages, and here are some steps you can take to protect yourself ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Stay home if they are sick until they no longer have a fever for 24 hours without using fever-reducing medicine. Return to ...

Levels of respiratory illnesses such as COVID-19, influenza and RSV are on the rise. Here’s what you can do to keep yourself ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...

As health officials report a surge of winter viruses, health experts are warning that heart disease symptoms can sometimes ...

Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

By Manuela Bianco Suarez University of Kentucky Healthcare This winter, low temperatures have impacted the state of Kentucky. One of the biggest concerns statewide is the rise in the number of ...

Through the week of Jan. 29, 19 states are reported "high" respiratory virus activity: Kansas, Nebraska, South Dakota, Minnesota, Iowa, Arkansas, Illinois, Indiana, Kentucky, Mississippi, Georgia, ...

The 30-day risk for death was slightly higher for COVID-19 than for influenza or RSV; the 180-day mortality also was higher for COVID-19.